The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

What is an Implantable Loop Recorder? Implantable Loop Recorder (ILR) or Insertable Cardiac Monitor is a small implantable device which monitors electrical heart activity and records the arrhythmias.

- Substantial rise in healthcare spending in Asia Pacific to fuel growth of the implantable loop recorders market in the region Heart-related disorders are a burden on healthcare systems worldwide, ...

Mofrad, P.S., Implantable loop monitors: patient perspective. Circulation, 2012. 126(25): p. e472-4. Cardiac Event Recorder - (http://www.heart.org/HEARTORG ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

May 10, 2005 (New Orleans) – Implantable loop recorders successfully provided a diagnosis in almost half of patients with unexplained syncope or presyncope, New York researchers reported at the Heart ...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Europe Implantable Loop Recorders Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. Key players in ...

August 14, 2003 — When evaluating select patients with recurrent unexplained syncope, a diagnostic strategy of prolonged primary monitoring using an implantable loop recorder is more cost effective ...

Wilmington, Delaware, United States, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global implantable loop recorders market was projected to attain US$ 1.3 billion in 2022.

Please provide your email address to receive an email when new articles are posted on . Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke ...

Dallas, Texas, Dec. 18, 2020 (GLOBE NEWSWIRE) -- The “Global Implantable Loop Recorders Market Size 2020, By Application (Atrial Fibrillation, Cardiac Arrhythmia, Cardiac Syncope) End Use (Hospitals, ...

Barcelona, Spain, 1 September 2009: The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering ...